Nonpermissive bone marrow environment impairs early B-cell development in common variable immunodeficiency.

Blood
Arianna TroiloMarta Rizzi

Abstract

Common variable immunodeficiency (CVID) is a disease characterized by increased susceptibility to infections, hypogammaglobulinemia, and immune dysregulation. Although CVID is thought to be a disorder of the peripheral B-cell compartment, in 25% of patients, early B-cell development in the bone marrow is impaired. Because poor B-cell reconstitution after hematopoietic stem cell transplantation has been observed, we hypothesized that in some patients the bone marrow environment is not permissive to B-cell development. Studying the differentiation dynamics of bone marrow-derived CD34+ cells into immature B cells in vitro allowed us to distinguish patients with B-cell intrinsic defects and patients with a nonpermissive bone marrow environment. In the former, immature B cells did not develop and in the latter CD34+ cells differentiated into immature cells in vitro, but less efficiently in vivo. In a further group of patients, the uncommitted precursors were unable to support the constant development of B cells in vitro, indicating a possible low frequency or exhaustion of the precursor population. Hematopoietic stem cell transplantation would result in normal B-cell repopulation in case of intrinsic B-cell defect, but in defective ...Continue Reading

References

Sep 2, 2005·Nature Reviews. Genetics·Keith D Robertson
Dec 13, 2005·Seminars in Immunology·Marion EspeliClaudine Schiff
Mar 7, 2007·The Journal of Immunology : Official Journal of the American Association of Immunologists·Antonello GiovannettiFernando Aiuti
Jan 15, 2008·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Aude Marie-CardineSerge Jacquot
May 18, 2011·Blood·Manuella L Gomes OchtropHans Hartmut Peter
Dec 20, 2011·Blood·Elena S ResnickCharlotte Cunningham-Rundles
Jan 1, 2014·The Journal of Immunology : Official Journal of the American Association of Immunologists·Helene KrausMarta Rizzi
Feb 11, 2014·Nature Immunology·Tanja A SchwickertMeinrad Busslinger
Jan 18, 2015·The Journal of Allergy and Clinical Immunology·Claudia WehrUNKNOWN Inborn Errors Working Party of the European Society for Blood and Marrow Transplantation and the European Society for Immuno
Mar 3, 2015·The Journal of Allergy and Clinical Immunology·Consuelo AnzilottiHelen Chapel
Nov 14, 2015·The Journal of Allergy and Clinical Immunology. in Practice·Francisco A BonillaKlaus Warnatz
Dec 22, 2015·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Vassilios LougarisAlessandro Plebani
Aug 4, 2016·Archivum Immunologiae Et Therapiae Experimentalis·William Rae
Dec 13, 2016·The Journal of Allergy and Clinical Immunology·Akihiro HoshinoHirokazu Kanegane
Feb 27, 2017·Clinical and Experimental Immunology·A-K KienzlerS Y Patel
Aug 31, 2018·The Journal of Experimental Medicine·Chris FistonichJoão P Pereira
Dec 14, 2018·International Journal of Molecular Sciences·Esther TamayoRamón Merino
Feb 6, 2019·Nature Immunology·Consuelo AnzilottiSophie Hambleton

❮ Previous
Next ❯

Citations

Apr 13, 2020·The Journal of Allergy and Clinical Immunology. in Practice·Federica PulvirentiIsabella Quinti
May 4, 2021·Frontiers in Immunology·Olivia A C LamersJoris van Montfrans

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.